Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 9Neoplasms 4Cancer Pain 4Agnosia 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuralgia 2Multiple Myeloma 2Lymphoma 2Inflammation 2Head and Neck Neoplasms 2Acute Pain 2Waldenstrom Macroglobulinemia 1Urinary Tract Infections 1Trigger Finger Disorder 1Thrombocythemia, Essential 1Stomatitis 1Staphylococcal Infections 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Squamous Cell Carcinoma of Head and Neck 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sezary Syndrome 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1

Interventions

Tramadol 1Oxycodone 1Hydrocodone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Intra-abdominal Cancer × Oxycodone × Clear all
NCT06232577 2026-05-14

5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
170 enrolled

Intra-abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡